Radiotherapy is an essential curative treatment modality for colorectal cancer. Apoptosis is the major mechanism of IR-induced cell death and aberrant apoptotic signaling results in radioresistance, w
Figure S1. (a) Tumor growth kinetics and response to radiotherapy administered twice-a-week alone or in combination with simultaneous MSC* injection. The combination of radiotherapy and MSC* reduced t
Peptide receptor radioligand therapy (PRRT) has evolved as an important second-line treatment option in the management of inoperable and metastatic neuroendocrine neoplasms (NEN). Though high radiatio
